Singapore markets closed

Emergent BioSolutions Inc. (EBS)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
57.14-0.33 (-0.57%)
At close: 4:00PM EDT
Currency in USD

Valuation measures

Market cap (intra-day) 53.07B
Enterprise value 33.52B
Trailing P/E 10.38
Forward P/E 111.18
PEG Ratio (5 yr expected) 10.88
Price/sales (ttm)1.80
Price/book (mrq)1.99
Enterprise value/revenue 32.06
Enterprise value/EBITDA 75.82

Trading information

Stock price history

Beta (5Y monthly) 0.91
52-week change 3-42.86%
S&P500 52-week change 335.11%
52-week high 3127.20
52-week low 355.07
50-day moving average 361.26
200-day moving average 367.38

Share statistics

Avg vol (3-month) 3486.21k
Avg vol (10-day) 3449.94k
Shares outstanding 553.7M
Implied shares outstanding 6N/A
Float 48.03M
% held by insiders 19.45%
% held by institutions 186.41%
Shares short (30 Aug 2021) 43.33M
Short ratio (30 Aug 2021) 49.12
Short % of float (30 Aug 2021) 47.69%
Short % of shares outstanding (30 Aug 2021) 46.20%
Shares short (prior month 29 Jul 2021) 43.72M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2020
Most-recent quarter (mrq)29 Jun 2021

Profitability

Profit margin 17.51%
Operating margin (ttm)28.68%

Management effectiveness

Return on assets (ttm)11.38%
Return on equity (ttm)21.82%

Income statement

Revenue (ttm)1.71B
Revenue per share (ttm)32.06
Quarterly revenue growth (yoy)0.70%
Gross profit (ttm)857.6M
EBITDA 604.4M
Net income avi to common (ttm)299.2M
Diluted EPS (ttm)5.50
Quarterly earnings growth (yoy)-95.00%

Balance sheet

Total cash (mrq)447.5M
Total cash per share (mrq)8.33
Total debt (mrq)897M
Total debt/equity (mrq)58.11
Current ratio (mrq)3.08
Book value per share (mrq)28.75

Cash flow statement

Operating cash flow (ttm)325.7M
Levered free cash flow (ttm)141.68M